The current financial score of Q32 Bio Inc is 8.99. Its financial status is robust, and its operating efficiency is high.
The current valuation score of Q32 Bio Inc is 9.32. Its current P/E ratio is 3.12, which is 145.46% below the recent high of 7.67 and 720.56% above the recent low of -19.38.
The current earnings forecast score of Q32 Bio Inc is 8.57. The average price target is 38.30, with a high of 59.00 and a low of 26.00.
The current price momentum score of Q32 Bio Inc is 4.59. Currently, the stock price is trading between the resistance level at 9.79 and the support level at 7.57, making it suitable for range-bound swing trading.
The current institutional shareholding score of Q32 Bio Inc is 5.00. The latest institutional shareholding proportion is 65.09%, representing a quarter-over-quarter increase of 1.14%.
The current risk assessment score of Q32 Bio Inc is 5.01. The company's beta value is 0.18. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.